Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response

PURPOSE: For patients with breast carcinoma, immunohistochemical markers are important factors in determining the breast cancer subtype and for establishing a therapeutic plan, including the use of neoadjuvant chemotherapy (NACT). However, it is not clear whether the expression of certain markers ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ho-chang, Ko, Hyoungsuk, Seol, Hyesil, Noh, Dong-Young, Han, Wonshik, Kim, Tae-You, Im, Seock-Ah, Park, In Ae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893341/
https://www.ncbi.nlm.nih.gov/pubmed/24454461
http://dx.doi.org/10.4048/jbc.2013.16.4.395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893341/
https://www.ncbi.nlm.nih.gov/pubmed/24454461
http://dx.doi.org/10.4048/jbc.2013.16.4.395

Ejemplares similares